Abstract
Leucine supplementation exerts a positive effect on mTOR pathway that is involved in the synthesis of skeletal muscle protein. In the present study, the capability of a 15-day dietary leucine supplementation (310 mg/kg) to improve the performance in acute high intensity effort and the inductive capacity on skeletal muscle protein anabolism in rats submitted to swimming exercise with a 10% bodyweight load attached to the tail, were studied. A 1.83-fold increase in mTOR gene expression in the treated group was found, while no changes in muscle protein content and rats body weight were observed. An increase in protein oxidation and a significant decrease in catalase were found in treated rats, while no changes in DNA damage, GSH and SOD levels were reported. We found an increase of superoxide anion and hydrogen peroxide/myeloperoxidase system in polymorphonuclear neutrophils obtained by treated group. These outcomes suggest slight enhancement in basal inflammation due to exercise activity via mTOR activation during treatment, without serious impairment of the antioxidant system and cell status. In conclusion, the 15-day leucine supplementation at the given dose, enhanced mTOR gene expression in the presence of acute effort which was also well tolerated by skeletal muscle, but probably too short to improve its anabolic activity.
Keywords: Antioxidant enzymes, comet assay, leucine, mTOR gene expression, respiratory burst.
Current Nutrition & Food Science
Title:Implications of Dietary Leucine on Muscle mTOR Gene Expression and Redox Status in Rats Following High Intensity Effort
Volume: 10 Issue: 4
Author(s): Manuel Carloni, Donatella Fedeli, Cinzia Nasuti, Nicola Sponsiello and Rosita Gabbianelli
Affiliation:
Keywords: Antioxidant enzymes, comet assay, leucine, mTOR gene expression, respiratory burst.
Abstract: Leucine supplementation exerts a positive effect on mTOR pathway that is involved in the synthesis of skeletal muscle protein. In the present study, the capability of a 15-day dietary leucine supplementation (310 mg/kg) to improve the performance in acute high intensity effort and the inductive capacity on skeletal muscle protein anabolism in rats submitted to swimming exercise with a 10% bodyweight load attached to the tail, were studied. A 1.83-fold increase in mTOR gene expression in the treated group was found, while no changes in muscle protein content and rats body weight were observed. An increase in protein oxidation and a significant decrease in catalase were found in treated rats, while no changes in DNA damage, GSH and SOD levels were reported. We found an increase of superoxide anion and hydrogen peroxide/myeloperoxidase system in polymorphonuclear neutrophils obtained by treated group. These outcomes suggest slight enhancement in basal inflammation due to exercise activity via mTOR activation during treatment, without serious impairment of the antioxidant system and cell status. In conclusion, the 15-day leucine supplementation at the given dose, enhanced mTOR gene expression in the presence of acute effort which was also well tolerated by skeletal muscle, but probably too short to improve its anabolic activity.
Export Options
About this article
Cite this article as:
Carloni Manuel, Fedeli Donatella, Nasuti Cinzia, Sponsiello Nicola and Gabbianelli Rosita, Implications of Dietary Leucine on Muscle mTOR Gene Expression and Redox Status in Rats Following High Intensity Effort, Current Nutrition & Food Science 2014; 10 (4) . https://dx.doi.org/10.2174/1573401310666141009212923
DOI https://dx.doi.org/10.2174/1573401310666141009212923 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Garlic (<i>Allium sativum</i> L.): Its Chemistry, Nutritional Composition, Toxicity,
and Anticancer Properties
Current Topics in Medicinal Chemistry Statins as Either Immunomodulators or Anti-Cancer Drugs: Functional Activities on Tumor Stromal Cells and Natural Killer Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
Current Medicinal Chemistry Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Current Drug Targets The Role of Melanocortin Peptides and Receptors in Regulation of Energy Balance
Current Pharmaceutical Design Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Current Cancer Drug Targets Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
Current Drug Targets Anti-IL-1 β Therapies
Recent Patents on DNA & Gene Sequences In vitro and in vivo Evaluation of Antitumor Drug-Loaded Aptamer Targeted Single-Walled Carbon Nanotubes System
Current Pharmaceutical Biotechnology Medical Treatment Of Elderly Patients With Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Drug Evolution Concept in Drug Design: 2. Chimera Method
Medicinal Chemistry Sudden Unexpected Death in Infancy and the Dilemma of Defining the Sudden Infant Death Syndrome
Current Pediatric Reviews Looking Beyond Inhibition of VEGF/mTOR: Emerging Targets for Renal Cell Carcinoma Drug Development
Current Clinical Pharmacology CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs
Current Pharmaceutical Design Circulating Biochemical Markers of Brain Damage in Infants Complicated by Ischemia Reperfusion Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Vascular Injury During Elevated Glucose can be Mitigated by Erythropoietin and Wnt Signaling
Current Neurovascular Research Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics
Current Gene Therapy Target Recognition Molecules and Molecular Modeling Studies
Current Topics in Medicinal Chemistry Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery